Chestnut Hill, MA, United States of America

Rosana Kapeller-Libermann

USPTO Granted Patents = 58 

 

 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 225(Granted Patents)

Forward Citations (Not Self Cited) = 217(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptidomimetic Macrocycles
IRAK Inhibitors
Human Diacylglycerol Acyltransferase
Amino Peptidases
Acyltransferases
Protein Kinases
Ubiquitin Proteases
Transferase Family Members
Nucleic Acid Sequences
Glycosyltransferases
Calpain-like Proteases
Adenylate Cyclases
58 patents (USPTO):Explore Patents

Title: The Innovative Journey of Rosana Kapeller-Libermann

Introduction: Rosana Kapeller-Libermann, a pioneering inventor based in Chestnut Hill, MA, has made significant contributions to the field of biotechnology with her groundbreaking innovations.

Latest Patents: Rosana Kapeller-Libermann's latest patents focus on novel therapies for autoimmune diseases, showcasing her commitment to developing cutting-edge solutions for complex medical conditions.

Career Highlights: With a background in molecular biology and a passion for translating scientific discoveries into tangible treatments, Rosana Kapeller-Libermann has led successful research teams and spearheaded projects that have the potential to revolutionize healthcare.

Collaborations: Throughout her career, Rosana Kapeller-Libermann has collaborated with leading research institutions, pharmaceutical companies, and academic experts to bring her inventions to life. Her collaborative spirit has been instrumental in driving forward progress in the biotechnology industry.

Conclusion: Rosana Kapeller-Libermann's dedication to innovation and her relentless pursuit of scientific excellence continue to inspire the next generation of inventors in the ever-evolving landscape of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…